Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis Slapped With $25,000 Fine For Breach In Medicines Australia Code Of Conduct

This article was originally published in PharmAsia News

Executive Summary

PERTH, Australia - Sanofi-Aventis Australia has agreed to pay a $25,000 fine to Medicines Australia and change its advertising, which was found to breach the code of conduct of the association that represents multinational pharmaceutical companies in Australia

You may also be interested in...



Pfizer Grilled By Australia’s TGA Over Payments To Pharmacists

Taking The Higher Moral Ground, Medicines Australia Adopts Tougher Code Of Conduct

PERTH, Australia - Beginning January 2010, Medicines Australia member companies will need to adhere to a stricter Code of Conduct, which sets the ethical standard for marketing and promotion of prescription medicines in Australia

Taking The Higher Moral Ground, Medicines Australia Adopts Tougher Code Of Conduct

PERTH, Australia - Beginning January 2010, Medicines Australia member companies will need to adhere to a stricter Code of Conduct, which sets the ethical standard for marketing and promotion of prescription medicines in Australia

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel